Shang Hai Zheng Quan Bao·2025-10-15 19:55Core Viewpoint - The company has announced a series of guarantees provided for its subsidiaries, totaling significant amounts, aimed at supporting their financing needs and ensuring operational stability [1][49]. Summary by Sections Guarantee Details - On October 14, 2025, the company signed a guarantee for its subsidiary, Fosun Pharma Industry, for a credit facility of RMB 700 million with China Merchants Bank, covering existing and new debts [1][11][13]. - A guarantee was also established for Fosun Health, covering a financing contract with a trust bank for up to RMB 150 million from October 14, 2025, to March 31, 2027 [2][16]. - On October 15, 2025, a guarantee was provided for Xuzhou Xingchen Hospital for a financing contract of up to RMB 157 million with SPD Bank [3][23]. - Additional guarantees were established for various subsidiaries, including Fosun Antigen, Hanjia Medical, and others, with amounts ranging from RMB 880,000 to RMB 10 million [5][31][39][45]. Cumulative Guarantee Situation - As of October 15, 2025, the total amount of guarantees provided by the group is approximately RMB 2,337.7 million, which represents 49.46% of the net assets attributable to shareholders as of December 31, 2024 [52]. Internal Decision-Making Process - The guarantees were approved by the company's board and the annual shareholders' meeting, ensuring compliance with internal governance procedures [8][50]. Necessity and Reasonableness of Guarantees - The guarantees are deemed necessary and reasonable, as they are intended to support the operational needs of the subsidiaries, with manageable risk levels [49]. Board Opinion - The board unanimously agreed on the necessity of the guarantees, considering them essential for the operational needs of the group and within the approved limits [50][51].